RFC4 is exhibited highly expressed and has significantly increased activity in various malignant tumors, including prostate, cervical, and colorectal cancers (Krause et al., 2001; Kang et al., 2009; Misbah et al., 2024). Here, RFC4 is linked to colorectal cancer.